EGFR and diabetic kidney disease: Interestingly, this study showed that ADAM17 upregulation in conditions of hyperglycemia might be self-augmented via an EGFR/ADAM17 signaling loop (Li et al., 2015) and further implicated ADAM17 as a target in treating diabetic kidney disease (Li et al., 2015).